Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890565 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)
A Phase 1 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 240
- Enrollment target
NCT00890565 is a Phase 1 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 240 participants.
The verdict
NCT00890565, a Phase 1 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study aims to evaluate the electrocardiogram (ECG) effects of Sancuso® compared to placebo and moxifloxacin in healthy subjects.
Interventions
- DRUG granisetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00890565
The ClinicalTrials.gov registry entry for NCT00890565 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin Co., which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which granisetron is the first listed.
NCT00890565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00890565 about?
NCT00890565 is a clinical study titled "Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)". This study aims to evaluate the electrocardiogram (ECG) effects of Sancuso® compared to placebo and moxifloxacin in healthy subjects.
What is the current status of trial NCT00890565?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 240 participants. The study started on 2009-05. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00890565?
The interventions under investigation include: granisetron (DRUG).
Who is sponsoring clinical trial NCT00890565?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.